Compassionate Use Programs or Phase IV Trials of Innovative Molecular Targeted Drugs in Lung Cancer
Combining Cytotoxic and Targeted Therapies for Lung Cancer
Sublobar Resection
National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository Originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654)
Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma
Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer
Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer
Looking Beyond Surveillance, Epidemiology, and End Results
Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients
Prognostic Factors for Survival after Surgical Palliation of Malignant Pleural Effusion
Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer
LungPoint—A New Approach to Peripheral Lesions
Cost-Benefit of Minimally Invasive Staging of Non-small Cell Lung Cancer
Tumor Invasion of Extralobar Soft Tissue Beyond the Hilar Region Does Not Affect the Prognosis of Surgically Resected Lung Cancer Patients
Prognostic Impact of Node Involvement Pattern in pN1 Non-small Cell Lung Cancer Patients
Sublobar Resection
Survival Differences by Gender for Resected Non-small Cell Lung Cancer
Safety and Resource Utilization by Non-small Cell Lung Cancer Histology
Efficacy and Safety of Erlotinib in 1242 East/South-East Asian Patients with Advanced Non-small Cell Lung Cancer
Erlotinib in Advanced Non-small Cell Lung Cancer
Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer
A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens
Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer
Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304)
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population
A Phase II Study of Sorafenib in Malignant Mesothelioma
Isotretinoin Plus Clindamycin Seem Highly Effective Against Severe Erlotinib-Induced Skin Rash in Advanced Non-small Cell Lung Cancer
A Brief Retrospective Report on the Feasibility of Epidermal Growth Factor Receptor and KRAS Mutation Analysis in Transesophageal Ultrasound- and Endobronchial Ultrasound-Guided Fine Needle Cytological Aspirates
Desire for Information and Involvement in Treatment Decisions
Lung Cancer Genomic Signatures
A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
Long-Term Survival of a Patient with Squamous Cell Carcinoma Harboring NUT Gene Rearrangement
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer
Fatal Pemetrexed-Induced Lung Injury in Patients with Advanced Mesothelioma
Evaluation of Kras Gene Mutation and Copy Number in Thymic Carcinomas and Thymomas
Leptomeningeal Metastases from Small Cell Lung Cancer Responsive to Temozolomide Therapy